| Bid price | 0.37 | Open price | 0.39 |
|---|---|---|---|
| Ask price | 0.45 | Prev close | 0.41 |
| High price | 0.37 | Spread | 17.78% |
| Low price | 0.35 | Volume | 1,771,931 |
Register now for FREE live ValiRx share prices, ValiRx stock quotes, charts, trades and FREE ValiRx company fundamentals, market news and much much more. Why not upgrade to a premium service and get ValiRx Level 2 Data, indepth research tools and investor commentary for ValiRx (VAL) and other London Stock Exchange equities.
Register now for FREE ValiRx share price charts
| Name | ValiRx | Epic | VAL |
|---|---|---|---|
| Activites | Provides therapeutic and diagnostic research and development | Reuters | VAL.L |
| ISIN | GB00B23N9136 | Google Finance | LON:VAL |
| Share Price (p) | 0.41 | Prev. Share Price (p) | 0.41 |
|---|---|---|---|
| Shares in Issue (m) | 1,260 | Market Cap (£m) | 5 |
| PE Ratio (x) | Div per share (p) | 0.00 | |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -0.10 | PEG |
Register now for FREE ValiRx company fundamentals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 14/07/2011 | BUY | Satu Vainikka | CEO | 1,235,555 |
| 14/07/2011 | BUY | George Morris | ED | 538,770 |
| 14/07/2011 | BUY | Gerald Desler | FD | 538,770 |
| 14/07/2011 | BUY | Kevin Alexander | NED | 538,770 |
| 14/07/2008 | SELL | Satu Vainikka | CEO | 16,667 |
ValiRx has announced that a method for cancer screening, using specific gene biomarkers in the field of genetics and oncology, has received patent approval by the US patent office. The granting of this latest patent means that ValiRx now has biomarker patent protection in both the US and across...
/* */ RNS Number : 3218D ValiRx PLC 15 May 2012 15 May 2012 ValiRx Plc ("ValiRx" or the "Company") New US Patent Grant for ValiRx's Cancer Screening Gene Biomarker ValiRx Plc (AIM: VAL), a life science company...
Register now for FREE ValiRx company news
Dr Satu Vainikka, CEO commented: "I am delighted that we are now launching our Chlamydia self-testing product into the UK and Irish markets. With Chlamydia being diagnosed as the fastest growing sexually transmitted disease at the moment, our self-testing pack, as an affordable, easy -to-use...
Register now for FREE ValiRx share price discussions